Veeco Instruments Inc. (VECO) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Veeco Instruments Inc. is a manufacturer of semiconductor and thin film process equipment, operating as a single reportable segment. The company serves four primary end-markets: Semiconductor, Compound Semiconductor, Data Storage, and Scientific & Other. As of July 30, 2024, there were 56,784,837 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Sales | $175.9 million | $161.6 million | $350.4 million | $315.1 million |
| Gross Profit | $75.4 million | $67.5 million | $150.8 million | $129.5 million |
| Gross Margin | 43% | 42% | 43% | 41% |
| Operating Income | $16.7 million | $13.7 million | $38.8 million | $23.5 million |
| Net Income | $14.9 million | ($85.3 million) Loss | $36.8 million | ($76.6 million) Loss |
| Diluted EPS | $0.25 | ($1.61) | $0.61 | ($1.48) |
| Cash & Equivalents | $174.2 million | Balance Sheet Data | ||
| Short-term Investments | $130.7 million | Balance Sheet Data | ||
| Total Debt (Current + Long-term) | $275.6 million | Balance Sheet Data | ||
| Operating Cash Flow (YTD) | $17.8 million | $25.1 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% in Q2 and 11% YTD compared to the prior year. This was driven by a 144% increase in Data Storage sales and a 3% increase in Semiconductor sales.
- Profitability Turnaround: The company returned to profitability in Q2 2024 ($14.9M net income) compared to a significant loss in Q2 2023 ($85.3M). The prior year loss was heavily impacted by a $97.1 million non-cash loss on the extinguishment of convertible notes.
- Margin Expansion: Gross margin improved to 43% in Q2 2024 from 42% in Q2 2023, attributed to higher sales volume and favorable product mix.
- Expense Management: Operating expenses increased 9% QoQ, primarily due to higher R&D spending ($31.7M vs $27.4M) to support new technology development.
Guidance, Outlook, and Risks
- Market Outlook: Management expects Semiconductor revenue to grow in 2024, driven by AI, high-performance computing, and High-Bandwidth Memory (HBM) demand. Data Storage revenue is expected to be flat to up. Compound Semiconductor and Scientific & Other markets are expected to be flat to down.
- Debt & Liquidity: The company has $281.5 million in principal outstanding on convertible notes (2025, 2027, and 2029 series). On August 2, 2024, the revolving credit facility was increased from $150 million to $225 million to ensure liquidity for potential note conversions.
- Key Risks:
- Geopolitical: Exposure to U.S.-China trade disputes and export controls.
- Customer Concentration: Reliance on a concentrated customer base in highly cyclical industries.
- Supply Chain: Dependence on a limited number of suppliers, some of whom are sole sources.
- Debt Covenants: Restrictions on the credit facility and potential dilution from convertible notes.
Investor Verification Checklist
- Convertible Note Conversion: Verify the status of the 2025, 2027, and 2029 notes, which are currently convertible by holders until September 30, 2024, and the company's ability to fund cash settlements if required.
- China Exposure: Assess the impact of ongoing trade restrictions on the 37% of Q2 revenue derived from China.
- R&D Efficiency: Monitor the return on increased R&D spending ($61.3M YTD) relative to future revenue growth in advanced logic and memory nodes.
- Inventory Levels: Review inventory balances ($245.1M) against sales trends to ensure no obsolescence risks in the cyclical semiconductor market.
- Contingent Consideration: Track the $22.3 million liability related to the Epiluvac acquisition milestones.